Stockhead on MSN
Orthocell flags rapid ‘hockey stick’ revenue growth in US$1.6 billion US nerve repair market
Nerve repair house Orthocell is thrilled about the rollout of its flagship Remplir device in the US and expects revenue to ...
Dr. Linda Girgis provides insightful commentary on a recent New York Times article, “Are AI Tools Making Doctors Worse at ...
Intuitive, the Californian pioneer in robotic surgery, aims for around thirty new hires per year at its Aubonne site through 2030.
Here's why TFSA investors should gain exposure to undervalued growth stocks and generate game-changing wealth over the next ...
A $100,000 fee for H-1B visas will particularly affect physicians trained in India who the U.S. can't afford to lose, writes ...
Find out how robotic technology for knee replacement surgery at Southlake Health is delivering personalized and precise care ...
Men are getting unnecessary treatment for prostate cancer because of greed in the urology community and the drug industry, University of Arizona immunobiologist Richard J. Ablin says in a new book ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results